GenrAb will be presenting at the IC3 Conference in Arlington, TX on October 3rd

GenrAb has been selected to present its recent data and provide a corporate update at the IC³ Conference in Arlington, TX on the afternoon of October 3rd. As one of the Rising Star companies selected by the senior review team at BIONTX, GenrAb’s Chief Medical Officer, Dr. Benjamin Greenberg, will review results on the company’s leading antibody therapy (TGM-010) as well as plans for expanding its pipeline of novel neuroprotective and neurotherapeutic antibodies. The Company will also have other members of its Sr. Management in attendance to meet with prospective partners and collaborators.